DAC-CEL T4— 510(k) K791231

Substantially Equivalent

Burroughs Wellcome Co.

FDA 510(k) clearance K791231 for DAC-CEL T4, Substantially Equivalent on 1979-09-04. Applicant: Burroughs Wellcome Co.. Device class: 2.

Clearance details

Applicant: Burroughs Wellcome Co.
Product code: Code CDX
Device class: Class 2
Regulation: 21 CFR 862.1700
Advisory panel: Clinical Chemistry
Date received: 1979-07-02
Decision date: 1979-09-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CDX

K961490 — ELECSYS T4 ASSAY1996-06-13
K954312 — ACTIVE THYROXINE RIA1995-10-07
K943416 — DELFIA NEONATAL THYROXINE KIT1995-03-10
K934384 — AXSYM(TM) TOTAL T41994-06-21
K932980 — TOTAL T4 FPIA REAGENT SET/CALIBRATOR #T-1039,T-1161993-10-18

More clearances from Burroughs Wellcome Co.

Data sourced from openFDA. This site is unofficial and independent of the FDA.